Literature DB >> 24236643

HNA-3 gene frequencies in Brazilians and a new polymerase chain reaction-restriction fragment length polymorphism method for HNA-3a/3b genotyping.

Larissa Barbosa Lopes1, Wilson Baleotti, Rodrigo Buzinaro Suzuki, Antonio Fabron, Akemi Kuroda Chiba, João Paulo Botelho Vieira-Filho, Bianca de Souza Castro, Alessandra Midori Kunioshi, José Orlando Bordin.   

Abstract

BACKGROUND: HNA-3 antigens are the result of a rs2288904 single-nucleotide polymorphism (SNP) in the CTL2, and the HNA-3a and HNA-3b variants are encoded by a guanine and adenine at Nucleotide Position 461. Anti-HNA-3 are involved in severe transfusion-related acute lung injury reactions and in neonatal alloimmune neutropenia. Since the distribution of the HNA-3 system was unknown in South Americans, in this study we determined the frequency of the HNA-3 alleles in Brazilians. STUDY DESIGN AND METHODS: DNA of 500 blood donors, 120 Xikrin Amerindians, 74 Japanese individuals, and 124 African Brazilians were genotyped for rs2288904 by a polymerase chain reaction (PCR)-restriction fragment length polymorphism assay. The PCR product was digested with enzyme Taq(α) 1, specific to nucleotide guanine (HNA-3a).
RESULTS: The results showed that the frequencies of the HNA-3a/HNA-3b alleles were 0.81/0.19 in blood donors, 1.00/0.00 in Amerindians, 0.63/0.37 in Japanese, and 0.85/0.15 in African Brazilians. All 81 individuals genotyped as HNA-3a/a did not present the SNP c.457T by molecular sequencing.
CONCLUSION: The frequencies of HNA-3 genotypes in Brazilian blood donors is similar to that described in Caucasians; however, all Amerindians were HNA-3a/a, African Brazilians showed a lower frequency of HNA-3b/b, and Japanese had a higher prevalence of HNA-3b/b, suggesting that they may be at risk for developing anti-HNA-3a alloantibodies.
© 2013 American Association of Blood Banks.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24236643     DOI: 10.1111/trf.12493

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  7 in total

1.  Full-length nucleotide sequences of 30 common SLC44A2 alleles encoding human neutrophil antigen-3.

Authors:  Qing Chen; Kshitij Srivastava; Stefanie C Ardinski; Kevin Lam; Michael J Huvard; Pirmin Schmid; Willy A Flegel
Journal:  Transfusion       Date:  2015-10-05       Impact factor: 3.157

2.  Antibodies against human neutrophil antigens in non-transfused women with red blood cell alloimmunisation induced by pregnancy.

Authors:  Juliana Oliveira Martins; Elyse Moritz; Samira A Abbas; Larissa B Lopes; Melca M O Barros; Akemi K Chiba; Dante M Langhi; José O Bordin
Journal:  Blood Transfus       Date:  2020-10-14       Impact factor: 3.443

3.  SLC44A2 Frequency, a New TaqMan Real-Time Polymerase Chain Reaction Method for HNA-3A/3B Genotyping, and a New Application of Droplet Digital PCR.

Authors:  Yufeng Wang; Xihui Chen; Qi Chen; Tangdong Chen; Kun Chen; Yuanming Wu; Li Wang
Journal:  Front Genet       Date:  2022-05-12       Impact factor: 4.772

4.  Genotype frequency of human neutrophil antigen-3 polymorphisms in the Yi, Han, and Tibetan populations of China.

Authors:  Qing Chen; Kshitij Srivastava; Zhong Liu; Jianyu Xiao; Chengyin Huang; Jun Sun; Min Li; Willy Albert Flegel
Journal:  Transfusion       Date:  2015-11-23       Impact factor: 3.157

Review 5.  Molecular Genetics of the Human Neutrophil Antigens.

Authors:  Brigitte Katharina Flesch; Angelika Reil
Journal:  Transfus Med Hemother       Date:  2018-08-17       Impact factor: 3.747

6.  Risk estimation of HNA-3 incompatibility and alloimmunization in Thai populations.

Authors:  Oytip Nathalang; Kamphon Intharanut; Kanokpol Siriphanthong; Siriporn Nathalang; Nipapan Leetrakool
Journal:  PLoS One       Date:  2015-01-21       Impact factor: 3.240

7.  HNA-3a and HNA-3b antigens among 9 ethnic populations and the Han population in Southwest China.

Authors:  Guo-Jin Ou; Pin-Can Su; Hao Yu; Xin Ji; Fan Liu; Sheng-Lan Wang; Yu-Jie Kong; Ling Li; Jue Wang; Zhong Liu; Willy Albert Flegel
Journal:  J Transl Med       Date:  2018-03-14       Impact factor: 5.531

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.